Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 374

1.

Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation.

Lehrich RW, Rocha PN, Reinsmoen N, Greenberg A, Butterly DW, Howell DN, Smith SR.

Hum Immunol. 2005 Apr;66(4):350-8.

PMID:
15866697
2.

Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection.

Rocha PN, Butterly DW, Greenberg A, Reddan DN, Tuttle-Newhall J, Collins BH, Kuo PC, Reinsmoen N, Fields T, Howell DN, Smith SR.

Transplantation. 2003 May 15;75(9):1490-5.

PMID:
12792502
3.

Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.

Ibernón M, Gil-Vernet S, Carrera M, Serón D, Moreso F, Bestard O, Cruzado JM, Grinyó JM.

Transplant Proc. 2005 Nov;37(9):3743-5.

PMID:
16386524
4.

Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection.

White NB, Greenstein SM, Cantafio AW, Schechner R, Glicklich D, McDonough P, Pullman J, Mohandas K, Boctor F, Uehlinger J, Tellis V.

Transplantation. 2004 Sep 15;78(5):772-4.

PMID:
15371687
5.

Plasmapheresis and intravenous immunoglobulin in early antibody-mediated rejection of the renal allograft: a single-center experience.

Slatinska J, Honsova E, Burgelova M, Slavcev A, Viklicky O.

Ther Apher Dial. 2009 Apr;13(2):108-12. doi: 10.1111/j.1744-9987.2009.00664.x.

PMID:
19379149
6.

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

Montgomery RA, Zachary AA, Racusen LC, Leffell MS, King KE, Burdick J, Maley WR, Ratner LE.

Transplantation. 2000 Sep 27;70(6):887-95.

PMID:
11014642
7.

Diagnosis and treatment of acute humoral kidney allograft rejection.

Gomes AM, Pedroso S, Martins LS, Malheiro J, Viscayno JR, Santos J, Dias L, Henriques AC, Sarmento AM, Cabrita A.

Transplant Proc. 2009 Apr;41(3):855-8. doi: 10.1016/j.transproceed.2009.01.062.

PMID:
19376371
8.
9.

Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin.

Shah A, Nadasdy T, Arend L, Brennan J, Leong N, Coppage M, Orloff M, Demme R, Zand MS.

Transplantation. 2004 May 15;77(9):1399-405.

PMID:
15167598
10.

Plasmapheresis in the treatment of early acute kidney allograft dysfunction.

Nafar M, Farrokhi F, Hemati K, Pour-Reza-Gholi F, Firoozan A, Einollahi B.

Exp Clin Transplant. 2006 Dec;4(2):506-9.

11.

[Acute humoral rejection of renal transplant].

Slatinská J, Honsová E, Lyerová L, Slavcev A, Viklický O.

Vnitr Lek. 2007 Mar;53(3):246-7, 249-52. Czech.

PMID:
17503638
12.
13.

Impact of rituximab therapy for treatment of acute humoral rejection.

Kaposztas Z, Podder H, Mauiyyedi S, Illoh O, Kerman R, Reyes M, Pollard V, Kahan BD.

Clin Transplant. 2009 Jan-Feb;23(1):63-73. doi: 10.1111/j.1399-0012.2008.00902.x.

PMID:
19200217
14.

Histological features of renal allograft biopsies in ABO minor-mismatched kidney transplantation.

Shimizu T, Tanabe K, Tokumoto T, Shimmura H, Ishikawa N, Ishida H, Toma H, Kawaguchi H, Tokiwa M, Yamaguchi Y.

Clin Transplant. 2003;17 Suppl 10:9-13.

PMID:
12823250
15.

C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption.

Böhmig GA, Regele H, Exner M, Derhartunian V, Kletzmayr J, Säemann MD, Hörl WH, Druml W, Watschinger B.

J Am Soc Nephrol. 2001 Nov;12(11):2482-9.

16.

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

Jordan SC, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, Toyoda M, Davis C, Shapiro R, Adey D, Milliner D, Graff R, Steiner R, Ciancio G, Sahney S, Light J.

J Am Soc Nephrol. 2004 Dec;15(12):3256-62.

17.

Plasmapheresis in C4d-positive acute humoral rejection following kidney transplantation: a review of 4 cases.

Lennertz A, Fertmann J, Thomae R, Illner WD, Hillebrand GE, Feucht HE, Land W, Samtleben W, Bosch T.

Ther Apher Dial. 2003 Dec;7(6):529-35.

PMID:
15018239
18.

Histopathology and outcome of acute humoral rejection in renal allografts.

Satoskar AA, Pelletier R, Nadasdy GM, Henry M, Ferguson R, Nadasdy T.

Front Biosci (Schol Ed). 2011 Jun 1;3:919-28.

PMID:
21622241
19.

Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.

Lefaucheur C, Nochy D, Andrade J, Verine J, Gautreau C, Charron D, Hill GS, Glotz D, Suberbielle-Boissel C.

Am J Transplant. 2009 May;9(5):1099-107. doi: 10.1111/j.1600-6143.2009.02591.x.

20.

Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.

Jin MK, Cho JH, Kwon O, Hong KD, Choi JY, Yoon SH, Park SH, Kim YL, Kim CD.

Transplant Proc. 2012 Jan;44(1):200-3. doi: 10.1016/j.transproceed.2011.11.040.

PMID:
22310614

Supplemental Content

Support Center